Loading clinical trials...
Loading clinical trials...
Effect of Addition of Modafinil on the Tolerability and Efficacy for Cognition of Atypical Antipsychotic Drugs in Patients With Schizophrenia or Schizoaffective Disorder
Conditions
Interventions
armodafinil (Nuvigil)
placebo
Locations
1
United States
Vanderbilt University Medical Center
Nashville, Tennessee, United States
Start Date
August 1, 2006
Primary Completion Date
January 1, 2010
Completion Date
January 1, 2010
Last Updated
August 5, 2025
NCT06894212
NCT06003036
NCT04226898
NCT05240976
NCT05304767
NCT07455929
Lead Sponsor
Northwestern University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions